[Clinical evaluation of side effects during immunotherapy with Catalet T in patients with hay fever].
The aim of this study was to evaluate the frequency of side effects during specific immunotherapy with Catalet T and to compare the frequency of side effects between different groups of patients according to time of immunotherapy continuation (from 1 to 5 years). The study was carried on 100 patients aged from 12 to 58 years. The tolerance of Catalet was good. 83% of investigated patients finished the immunotherapy course with minimal or no side effects. The prevalence of side effects was the same independently from the time of immunotherapy.
Kurowski
W
W
Zakładu Alergologii PSK Nr I w Gdańsku.
Sopel
R
R
Mincewicz
G
G
Kozłowski
M
M
D000293:Adolescent; D000328:Adult; D002648:Child; D003231:Conjunctivitis / Q000209:etiology; D004417:Dyspnea / Q000209:etiology; D005260:Female; D006801:Humans; D007167:Immunotherapy / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011058:Pollen; D006255:Rhinitis, Allergic, Seasonal / Q000628:therapy*; D014581:Urticaria / Q000209:etiology; D014612:Vaccines; D014614:Vaccines, Synthetic / Q000009:adverse effects*
D014612:Vaccines; D014614:Vaccines, Synthetic; C082987:catalet
Kliniczna ocena objawów ubocznych w trakcie odczulania preparatem Catalet T chorych na pyłkowice.